4.4 Article

Changes in HIV treatment differentiated care uptake during the COVID-19 pandemic in Zambia: interrupted time series analysis

Related references

Note: Only part of the references are listed.
Article Immunology

Community-based delivery of HIV treatment in Zambia: costs and outcomes

Brooke E. Nichols et al.

Summary: The study aimed to compare the total annual cost per patient treated and total cost per patient retained on antiretroviral therapy in Zambia between conventional care and community-based differentiated service delivery (DSD) models. The results showed that DSD models had higher costs but also higher retention rates compared to conventional care.
Article Medicine, Research & Experimental

A comparison of different community models of antiretroviral therapy delivery with the standard of care among stable HIV plus patients: rationale and design of a non-inferiority cluster randomized trial, nested in the HPTN 071 (PopART) study

Mohammed Limbada et al.

Summary: This study aims to evaluate the safety and efficacy of non-facility-based delivery of ART for stable PLHIV in high-burden resource-limited settings through rigorous randomized evidence, and will inform policy regarding best practices and how to strengthen the scale-up of differentiated models of ART delivery in resource-limited settings.

TRIALS (2021)

Article Public, Environmental & Occupational Health

Differentiated Service Delivery Models for HIV Treatment in Malawi, South Africa, and Zambia: A Landscape Analysis

Amy Huber et al.

Summary: As of 2019, a large variety of differentiated service models were being offered for HIV treatment in Malawi, South Africa, and Zambia, serving diverse patient populations.

GLOBAL HEALTH-SCIENCE AND PRACTICE (2021)

Article Immunology

Acceleration of differentiated service delivery for HIV treatment in sub-Saharan Africa during COVID-19

Anna Grimsrud et al.

Summary: Across Sub-Saharan Africa in 2020, countries have adapted and accelerated policies supporting differentiated service delivery for HIV treatment in response to COVID-19. These adaptations include expanding eligibility for DSD, extending multi-month dispensing, emphasizing community-based models, and integrating other chronic medications with ART. These measures have proven beneficial for HIV patients during the pandemic and aim to establish a new normal for HIV treatment policies.

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2021)

Review Immunology

Expanding the Vision for Differentiated Service Delivery: A Call for More Inclusive and Truly Patient-Centered Care for People Living With HIV

Peter Ehrenkranz et al.

Summary: Integrating services into differentiated service delivery platforms can improve healthcare coverage for PLHIV, while the existing fragmented service model increases burden on both patients and health systems.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)

Article Public, Environmental & Occupational Health

First 100 Persons with COVID-19-Zambia, March 18-April 28, 2020

Peter J. Chipimo et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Public, Environmental & Occupational Health

Medication Adherence Clubs: a potential solution to managing large numbers of stable patients with multiple chronic diseases in informal settlements

Kelly B. Khabala et al.

TROPICAL MEDICINE & INTERNATIONAL HEALTH (2015)